Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Vaccine Safety”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Study completedNCT01725217
What this trial is testing

Immunogenicity and Safety of Meningococcal ACWY Conjugate Vaccine in Healthy Children, Adolescents and Adults in Russia

Who this might be right for
Meningococcal Disease
Novartis Vaccines 198
Early research (Phase 1)Study completedNCT04316689
What this trial is testing

First-in-human Study of S-588210 (S-488210+S-488211)

Who this might be right for
Lung CancerHead and Neck CancerBladder Cancer+2 more
Shionogi 10
Early research (Phase 1)Study completedNCT00140738
What this trial is testing

Safety and Immunogenicity Study of the New dHER2 Vaccine to Treat HER2-positive Metastatic Breast Cancer

Who this might be right for
Neoplasms, Breast
GlaxoSmithKline 3
Large-scale testing (Phase 3)Study completedNCT00366548
What this trial is testing

Study to Evaluate a 13-valent Pneumococcal Conjugate Vaccine in Infants

Who this might be right for
Vaccines, Pneumococcal
Wyeth is now a wholly owned subsidiary of Pfizer 500
Testing effectiveness (Phase 2)Study completedNCT02678455
What this trial is testing

Safety and Immunogenicity of the Dengue Virus Vaccine TV005 (TetraVax-DV TV005) in Healthy Adults, Adolescents, and Children in Dhaka, Bangladesh

Who this might be right for
Dengue
National Institute of Allergy and Infectious Diseases (NIAID) 192
Early research (Phase 1)Study completedNCT00680589
What this trial is testing

Patients With Mouse Tyrp2 DNA: A Phase I Trial to Assess Safety and Immune Response

Who this might be right for
Melanoma
Memorial Sloan Kettering Cancer Center 12
Large-scale testing (Phase 3)UnknownNCT05602558
What this trial is testing

The Phase Ⅱ/Ⅲ Trial of LYB001

Who this might be right for
COVID-19
Yantai Patronus Biotech Co., Ltd. 18,000
Large-scale testing (Phase 3)Study completedNCT00881842
What this trial is testing

Annual Study to Investigate Inactivated Subunit Influenza Vaccine Due to New Virus Strains for the 09/10 Season

Who this might be right for
Influenza
Abbott Biologicals 120
Early research (Phase 1)Study completedNCT00814229
What this trial is testing

Safety and Immunogenicity of Influenza H9 Vaccine in Humans

Who this might be right for
Influenza
University Hospitals, Leicester 353
Post-approval studies (Phase 4)Study completedNCT02915302
What this trial is testing

Safety and Immunogenicity of Fluzone® Quadrivalent Vaccine Administered to Healthy Children

Who this might be right for
Influenza
Sanofi Pasteur, a Sanofi Company 1,950
Testing effectiveness (Phase 2)Study completedNCT05198102
What this trial is testing

ZF2001 Booster Immunization Clinical Trials of 12 Months After the Completion of Basic Immunization

Who this might be right for
Prevention of COVID-19
Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd. 300
Early research (Phase 1)Study completedNCT02508896
What this trial is testing

Study Assessing Safety, Immunogenicity and LDLc -Lowering Activity of 2 PCSK9 Targeting AFFITOPE Vaccines in Healthy Subjects

Who this might be right for
Hypercholesterolemia
Affiris AG 72
Post-approval studies (Phase 4)Study completedNCT04952727
What this trial is testing

Study on Sequential Immunization of Inactivated COVID-19 Vaccine and Recombinant COVID-19 Vaccine (Ad5 Vector) in Elderly Adults

Who this might be right for
COVID-19
Jiangsu Province Centers for Disease Control and Prevention 300
Not applicableUnknownNCT04724642
What this trial is testing

COVID-19 Vaccine in Patients After Allogeneic HCT, CAR-T Therapy and With Primary Immune Deficiency

Who this might be right for
Allogenic Hematopoietic Cell TransplantCAR-T TherapyPrimary Immunodeficiency
Tel-Aviv Sourasky Medical Center 110
Post-approval studies (Phase 4)Study completedNCT00561002
What this trial is testing

Phase IV Trial to Collect Safety Data and Sera for Immunogenicity Testing in Healthy Children Given Fluzone® Vaccine

Who this might be right for
Influenza
Sanofi Pasteur, a Sanofi Company 34
Testing effectiveness (Phase 2)Study completedNCT00730288
What this trial is testing

Study of ChimeriVax™ Dengue Tetravalent Vaccine in Adult Subjects

Who this might be right for
DengueDengue FeverDengue Hemorrhagic Fever+1 more
Sanofi 35
Large-scale testing (Phase 3)Study completedNCT06399003
What this trial is testing

Comparison Study of SIBP's MMR Vaccine Versus GSK MMR Vaccine in Children Aged 9-11 Months

Who this might be right for
Measles-Mumps-Rubella
Shanghai Institute Of Biological Products 1,200
Early research (Phase 1)Study completedNCT05875961
What this trial is testing

Study to Evaluate Immunogenicity, Safety and Tolerability of Adjuvanted and Non-Adjuvanted H2N3 Influenza Vaccines in Adults

Who this might be right for
Influenza, HumanInfectionsRespiratory Tract Infections+2 more
Seqirus 600
Early research (Phase 1)Study completedNCT02718469
What this trial is testing

Trial to Evaluate Safety and Immunogenicity of an Ebola Zaire Vaccine in Healthy Adults

Who this might be right for
Ebola Virus Disease
Auro Vaccines LLC 38
Testing effectiveness (Phase 2)Study completedNCT00306566
What this trial is testing

Safety and Immunogenicity of a Melan-A VLP Vaccine in Early Stage Melanoma Patients

Who this might be right for
Malignant Melanoma
Cytos Biotechnology AG
Next Page